Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial

BACKGROUND: People with severe mental illness (SMI) are two to three times more likely to be overweight and obese than the general population and this is associated with significant morbidity and premature mortality. Although lifestyle interventions can support people with SMI to lose weight, some a...

Descripción completa

Detalles Bibliográficos
Autores principales: Whicher, Clare Alexandra, Price, Hermione Clare, Phiri, Peter, Rathod, Shanaya, Barnard-Kelly, Katharine, Reidy, Claire, Thorne, Kerensa, Asher, Carolyn, Peveler, Robert, McCarthy, Joanne, Holt, Richard Ian Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868690/
https://www.ncbi.nlm.nih.gov/pubmed/31747930
http://dx.doi.org/10.1186/s13063-019-3689-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868690/
https://www.ncbi.nlm.nih.gov/pubmed/31747930
http://dx.doi.org/10.1186/s13063-019-3689-5

Ejemplares similares